ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2851

NF-Κappa b Signaling in the Myeloid Cell Lineage Drives the Pathogenesis of Immune-Mediated Nephritis

Samantha Chalmers1, Sayra Garcia1, Justine Shum1, Leal Herlitz2 and Chaim Putterman3, 1Albert Einstein College of Medicine, Bronx, NY, 2Cleveland Clinic, Cleveland, OH, 3Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, USA, Bronx, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Lupus, Lupus nephritis, Macrophage, nephritis and pathogenesis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: 5T105 ACR Abstract: Innate Immunity (2850–2855)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:

Immune-mediated glomerulonephritis is a serious end organ pathology that commonly affects patients with systemic lupus erythematosus (SLE). Nephrotoxic serum nephritis, induced by passive transfer of preformed nephrotoxic antibodies, is a mouse model commonly used to study lupus nephritis (LN). We and others have previously shown that macrophages are important in the pathogenesis of LN. To further delineate critical nephritis-associated pathways, in this study we assessed the importance of NF-kB signaling in the myeloid cell lineage in the pathogenesis of LN.

Methods:

Using flox-cre technology, we created a novel B6 mouse strain with genetic deficiency in RelA (aka p65) restricted to myeloid cells (RelA flox/flox LyzM cre/cre B6; KO mice), thus facilitating the study of the role of classical NF-kB signaling in myeloid cells in the context of immune mediated nephritis. Lupus like nephritis was induced at 9-10 weeks of age in both the KO mice and age-matched wildtype control B6 mice (WT mice). Mice were immunized on day 0 with rabbit IgG emulsified in complete Freund’s adjuvant, and 5 days later were given the nephrotoxic serum (containing rabbit antibodies which target murine glomerular antigens) by intravenous injection. Mice were then serially assessed for the development of nephritis.

Results:

By day 13, myeloid cell RelA KO mice (n=14) injected with nephrotoxic serum had significantly attenuated proteinuria (mean protein:creatinine ratio KO=3.1 ± 2.2 vs. WT=29.0 ± 9.0, p<0.05) and lower serum BUN levels (mean KO= 46.0 ± 5.7 mg/dL vs. WT 69.9 ± 6.2 mg/dL, p<0.01) compared to control injected WT mice (n=16). Inhibiting myeloid NF-κB signaling also decreased inflammatory modulators within the kidneys. We found significant decreases in expression of IL-1a, IFNg, and IL-6 in kidneys from KO mice, but higher IL-10 expression. We also found a significant reduction of macrophages accumulating in the kidney by immunofluorescent staining, a finding confirmed by flow cytometry. Specifically, flow cytometric analysis revealed decreased numbers of classically activated macrophages infiltrating the kidneys of KO mice. Kidney IgG and C3 deposition, however, was not different between KO and WT mice. Additionally, the two strains had no differences in their antibody response to the initial immunization (in both total IgG concentration and concentrations of different isotypes), indicating that any differences in disease severity were not because deficient myeloid NF-κB signaling interfered with disease induction. Analysis of renal histopathology is pending.

Conclusion:

Our studies indicate that macrophage NF-κB signaling is instrumental in the contribution of this cell type to the pathogenesis of nephritis induced by pathogenic antibodies. These results suggest that while approaches which decrease macrophage numbers can be effective in LN, more targeted treatments directed at modulating macrophage signaling and/or function could be beneficial, at least in early stages of the disease.


Disclosure: S. Chalmers, None; S. Garcia, None; J. Shum, None; L. Herlitz, None; C. Putterman, None.

To cite this abstract in AMA style:

Chalmers S, Garcia S, Shum J, Herlitz L, Putterman C. NF-Κappa b Signaling in the Myeloid Cell Lineage Drives the Pathogenesis of Immune-Mediated Nephritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/nf-%ce%baappa-b-signaling-in-the-myeloid-cell-lineage-drives-the-pathogenesis-of-immune-mediated-nephritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nf-%ce%baappa-b-signaling-in-the-myeloid-cell-lineage-drives-the-pathogenesis-of-immune-mediated-nephritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology